Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05379270
Other study ID # NCR213471
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 28, 2022
Est. completion date July 31, 2024

Study information

Verified date September 2023
Source George Washington University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to measure the widely consumed low-calorie sweeteners (LCS) sucralose and acesulfame-potassium, in maternal breast milk and plasma at pre-specified timepoints over 72 hours and in a single sample of infants' plasma. Sucralose and acesulfame-potassium concentrations will be measured using liquid chromatography-mass spectrometry (LC-MS). The data generated will inform the design of larger, longer-term, prospective studies needed to investigate clinically-relevant consequences of early life LCS exposure in humans.


Description:

Low-calorie sweetener (LCS) consumption is highly prevalent among lactating women, yet the current understanding of LCS effects on diet, weight, and health is extremely limited, especially when exposure begins early in life. This project aims to measure the widely consumed LCSs, sucralose and acesulfame-potassium, in maternal breast milk and plasma, at pre-specified, time-points over the course of 72 hours, and in a single sample of infants' plasma (analyzed using a population pharmacokinetics approach). Mothers will attend an enrollment visit, which will take place virtually and will schedule an in-person visit to take place at Children's National Hospital approximately one week later. During the enrollment visit, informed consent will be obtained and demographic, anthropometric, and dietary data will be collected. During the week prior to their scheduled in-person study visit, mothers will be instructed to continue their usual dietary habits and to complete an online, photo-assisted, 7-day food record. Mothers will be instructed to arrive fasted for the in-person visit, which will last for approximately 13 hours. Following ingestion of a diet beverage containing sucralose and ace-K, mothers will remain at Children's National for supervised serial sample collection at pre-determined time points over 12 hours, and will provide additional samples on three subsequent consecutive days (72 hours). Mothers will be instructed to continue to complete the online, photo-assisted, food record for the three days following the in-person study visit (until 72 hours following diet beverage consumption). A plasma sample will be collected from each infant via heel-stick at one of the following pre-specified time intervals following the mother's ingestion of the diet beverage: 1.5-3 hours, 3-5 hours, 5-7 hours, 7-9 hours, 9-14 hours, and 22-36 hours.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 41
Est. completion date July 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - mother gave birth within the past 6 months - mother =18 years of age - exclusively breastfeeding - reports consumption of diet, low-calorie sweetener-containing beverages = 1 time per week. - infants' corrected age >= 4 weeks Exclusion Criteria: - known allergy or contraindication to sucralose or acesulfame-potassium (infant or mother) - active nutritional disorder known to cause malabsorption

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diet soda
Participants will be asked to drink 24 ounces of a commercially-available diet beverage sweetened with sucralose and acesulfame-potassium.

Locations

Country Name City State
United States The George Washington University Washington District of Columbia

Sponsors (1)

Lead Sponsor Collaborator
George Washington University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Baseline sucralose concentrations in breast milk Sucralose will be measured in breast milk baseline (pre-diet beverage)
Primary 1-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 1 hour after diet beverage ingestion
Primary 2-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 2 hours after diet beverage ingestion
Primary 3-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 3 hours after diet beverage ingestion
Primary 4-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 4 hours after diet beverage ingestion
Primary 6-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 6 hours after diet beverage ingestion
Primary 8-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 8 hours after diet beverage ingestion
Primary 12-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 12 hours after diet beverage ingestion
Primary 24-hour sucralose concentrations in breast milk Sucralose will be measured in breast milk 24 hours after diet beverage ingestion
Primary Baseline acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk Baseline (prior to diet beverage ingestion)
Primary 1-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 1 hour after diet beverage ingestion
Primary 2-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 2 hours after diet beverage ingestion
Primary 3-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 3 hours after diet beverage ingestion
Primary 4-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 4 hours after diet beverage ingestion
Primary 6-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 6 hours after diet beverage ingestion
Primary 8-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 8 hours after diet beverage ingestion
Primary 12-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 12 hours after diet beverage ingestion
Primary 24-hour acesulfame-potassium concentrations in breast milk Acesulfame-potassium will be measured in breast milk 24 hours after diet beverage ingestion
Primary Baseline sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma baseline (before diet beverage ingestion)
Primary 30-min sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 30 minutes after diet beverage ingestion
Primary 1 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 1 hour after diet beverage ingestion
Primary 1.5 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 1.5 hours after diet beverage ingestion
Primary 2 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 2 hours after diet beverage ingestion
Primary 3 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 3 hours after diet beverage ingestion
Primary 4 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 4 hours after diet beverage ingestion
Primary 6 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 6 hours after diet beverage ingestion
Primary 8 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 8 hours after diet beverage ingestion
Primary 12 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 12 hours after diet beverage ingestion
Primary 24 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 24 hours after diet beverage ingestion
Primary 48 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 48 hours after diet beverage ingestion
Primary 72 hour sucralose concentration in maternal plasma Sucralose concentrations will be measured in maternal plasma 72 hours after diet beverage ingestion
Primary Baseline acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma baseline (before diet beverage ingestion)
Primary 30 min acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 30 minutes after diet beverage ingestion
Primary 1 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 1 hour after diet beverage ingestion
Primary 1.5 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 1.5 hours after diet beverage ingestion
Primary 2 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 2 hours after diet beverage ingestion
Primary 3 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 3 hours after diet beverage ingestion
Primary 4 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 4 hours after diet beverage ingestion
Primary 6 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 6 hours after diet beverage ingestion
Primary 8 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 8 hours after diet beverage ingestion
Primary 12 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 12 hours after diet beverage ingestion
Primary 24 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 24 hours after diet beverage ingestion
Primary 48 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 48 hours after diet beverage ingestion
Primary 72 hour acesulfame-potassium concentrations in maternal plasma Acesulfame-potassium will be measured in maternal plasma 72 hours after diet beverage ingestion
Primary Sucralose concentrations in infant plasma Sucralose will be measured in infant plasma at a single timepoint following ingestion of the diet beverage varies across infants
Primary Acesulfame-potassium concentrations in infant plasma Acesulfame-potassium will be measured in infant plasma at a single timepoint following ingestion of the diet beverage varies across infants
See also
  Status Clinical Trial Phase
Completed NCT00579605 - Motivational Interviewing to Promote Sustained Breastfeeding N/A
Completed NCT05655364 - Development of a Breastfeeding Supportive Mobile Application N/A
Completed NCT03853850 - Using Mobile Phone Text Messaging System to Improve Exclusive Breastfeeding Rate in a Resource-poor Caribbean Island N/A
Completed NCT03957941 - FamilyLink and Breastfeeding N/A
Withdrawn NCT03709004 - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression N/A
Completed NCT02958475 - Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers N/A
Active, not recruiting NCT05503069 - Community Interventions to Improve Breastfeeding N/A
Not yet recruiting NCT02233439 - Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues N/A
Completed NCT01893736 - Professional Breastfeeding Support Intervention N/A
Completed NCT02738957 - Effect of Prenatal Counseling on Breastfeeding Rates in Twins N/A
Completed NCT00527956 - Facilitation and Barriers to Breastfeeding in the NICU N/A
Completed NCT03655314 - Using the Electronic Health Record to Guide Management of Newborn Weight Loss N/A
Completed NCT05562245 - Motivational Interviewing-Based Breastfeeding Education N/A
Completed NCT05106634 - Evaluation of Breastfeeding Success and Self-Efficacy in Mothers Giving Birth Via Vaginal Delivery or Cesarean Section
Completed NCT05992753 - Mothers' Breast Milk Expression Experiences, Infant Feeding Attitudes and Perceived Social Support Levels
Recruiting NCT05250219 - Microchimeric Cell Tranfer From Mother to Child - Pilo Study
Recruiting NCT05213975 - Kinesio Taping Application After Cesarean Section N/A
Recruiting NCT05371106 - Mycotoxins in Mothers Milk in Israel
Completed NCT03332108 - Novel Approach To Improving Lactation Support With Mobile Health Technology N/A
Completed NCT02901665 - Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes N/A